Alprazolam Tablets — Class II drug recall D-0567-2022
Terminated recall by ANI Pharmaceuticals, Inc., reported 2022-02-23, distributed nationwide. cGMP Deviations
| Recall number | D-0567-2022 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | ANI Pharmaceuticals, Inc., Baudette, MN, United States |
| Recall initiated | 2022-02-15 |
| Classified | 2022-02-17 |
| Reported by FDA | 2022-02-23 |
| Terminated | 2022-10-25 |
| Distributed | Nationwide (US) |
| Quantity | 70,788 bottles |
| Reason classes | cgmp |
| NDC | 67253-0903-10, 67253-0903-50 |
| Expiration dates | 2022-03, 2022-04, 2022-05 |
Product
Alprazolam Tablets, USP 2.0 mg, packaged in a) 100-count bottles (NDC 67253-903-10), b) 500-count bottles (NDC 67253-903-50), Rx only, Distributed by: Par Pharmaceutical Chestnut Ridge, NY 10977
Reason for recall
cGMP Deviations
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0567-2022. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.